The IPO window doesn’t appear to be opening anytime soon, but life sciences lawyers expect mergers—and regulatory challenges—to pick up this year.
A 'Bellwether' Year for Life Sciences: Lawyers Forecast M&A Uptick as Regs Remain Busy
Leave a Reply